HEADER SIGNALING PROTEIN 14-JAN-20 6VIX TITLE BRD4_BROMODOMAIN2 COMPLEX WITH PYRROLOPYRIDONE COMPOUND 18 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: BROMODOMAIN 2; COMPND 5 SYNONYM: PROTEIN HUNK1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BROMODOMAIN, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.L.LONGENECKER,C.H.PARK,W.QIU REVDAT 3 11-OCT-23 6VIX 1 REMARK REVDAT 2 10-JUN-20 6VIX 1 JRNL REVDAT 1 06-MAY-20 6VIX 0 JRNL AUTH G.S.SHEPPARD,L.WANG,S.D.FIDANZE,L.A.HASVOLD,D.LIU,J.K.PRATT, JRNL AUTH 2 C.H.PARK,K.LONGENECKER,W.QIU,M.TORRENT,P.J.KOVAR,M.BUI, JRNL AUTH 3 E.FAIVRE,X.HUANG,X.LIN,D.WILCOX,L.ZHANG,Y.SHEN,D.H.ALBERT, JRNL AUTH 4 T.J.MAGOC,G.RAJARAMAN,W.M.KATI,K.F.MCDANIEL JRNL TITL DISCOVERY OFN-ETHYL-4-[2-(4-FLUORO-2,6-DIMETHYL-PHENOXY) JRNL TITL 2 -5-(1-HYDROXY-1-METHYL-ETHYL) JRNL TITL 3 PHENYL]-6-METHYL-7-OXO-1H-PYRROLO[2, JRNL TITL 4 3-C]PYRIDINE-2-CARBOXAMIDE (ABBV-744), A BET BROMODOMAIN JRNL TITL 5 INHIBITOR WITH SELECTIVITY FOR THE SECOND BROMODOMAIN. JRNL REF J.MED.CHEM. V. 63 5585 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32324999 JRNL DOI 10.1021/ACS.JMEDCHEM.0C00628 REMARK 2 REMARK 2 RESOLUTION. 2.12 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 (29-NOV-2019) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 82.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 30976 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1556 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 51 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.49 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 620 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2135 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 588 REMARK 3 BIN R VALUE (WORKING SET) : 0.2144 REMARK 3 BIN FREE R VALUE : 0.1965 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.16 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 32 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3526 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 140 REMARK 3 SOLVENT ATOMS : 327 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.18 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.71660 REMARK 3 B22 (A**2) : -7.77350 REMARK 3 B33 (A**2) : 4.05680 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.80640 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.260 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.229 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.179 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.213 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.175 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.904 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3770 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5082 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1322 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 662 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3770 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 438 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3093 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.93 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.02 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.38 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6VIX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JAN-20. REMARK 100 THE DEPOSITION ID IS D_1000246463. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30976 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.116 REMARK 200 RESOLUTION RANGE LOW (A) : 82.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.12 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.58000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 5UVS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 3350, 0.2M AMSO4, 0.1M NA REMARK 280 CACODYLATE, PH 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 81.21000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.35500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 81.21000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 20.35500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 348 REMARK 465 SER A 349 REMARK 465 MET A 457 REMARK 465 GLY B 348 REMARK 465 SER B 349 REMARK 465 GLY C 348 REMARK 465 MET C 457 REMARK 465 GLY D 348 REMARK 465 SER D 349 REMARK 465 MET D 457 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue QYV A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue QYV B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue QYV C 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue QYV D 501 DBREF 6VIX A 352 457 UNP O60885 BRD4_HUMAN 352 457 DBREF 6VIX B 352 457 UNP O60885 BRD4_HUMAN 352 457 DBREF 6VIX C 352 457 UNP O60885 BRD4_HUMAN 352 457 DBREF 6VIX D 352 457 UNP O60885 BRD4_HUMAN 352 457 SEQADV 6VIX GLY A 348 UNP O60885 EXPRESSION TAG SEQADV 6VIX SER A 349 UNP O60885 EXPRESSION TAG SEQADV 6VIX HIS A 350 UNP O60885 EXPRESSION TAG SEQADV 6VIX MET A 351 UNP O60885 EXPRESSION TAG SEQADV 6VIX GLY B 348 UNP O60885 EXPRESSION TAG SEQADV 6VIX SER B 349 UNP O60885 EXPRESSION TAG SEQADV 6VIX HIS B 350 UNP O60885 EXPRESSION TAG SEQADV 6VIX MET B 351 UNP O60885 EXPRESSION TAG SEQADV 6VIX GLY C 348 UNP O60885 EXPRESSION TAG SEQADV 6VIX SER C 349 UNP O60885 EXPRESSION TAG SEQADV 6VIX HIS C 350 UNP O60885 EXPRESSION TAG SEQADV 6VIX MET C 351 UNP O60885 EXPRESSION TAG SEQADV 6VIX GLY D 348 UNP O60885 EXPRESSION TAG SEQADV 6VIX SER D 349 UNP O60885 EXPRESSION TAG SEQADV 6VIX HIS D 350 UNP O60885 EXPRESSION TAG SEQADV 6VIX MET D 351 UNP O60885 EXPRESSION TAG SEQRES 1 A 110 GLY SER HIS MET GLU GLN LEU LYS CYS CYS SER GLY ILE SEQRES 2 A 110 LEU LYS GLU MET PHE ALA LYS LYS HIS ALA ALA TYR ALA SEQRES 3 A 110 TRP PRO PHE TYR LYS PRO VAL ASP VAL GLU ALA LEU GLY SEQRES 4 A 110 LEU HIS ASP TYR CYS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 A 110 MET SER THR ILE LYS SER LYS LEU GLU ALA ARG GLU TYR SEQRES 6 A 110 ARG ASP ALA GLN GLU PHE GLY ALA ASP VAL ARG LEU MET SEQRES 7 A 110 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU SEQRES 8 A 110 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 A 110 MET ARG PHE ALA LYS MET SEQRES 1 B 110 GLY SER HIS MET GLU GLN LEU LYS CYS CYS SER GLY ILE SEQRES 2 B 110 LEU LYS GLU MET PHE ALA LYS LYS HIS ALA ALA TYR ALA SEQRES 3 B 110 TRP PRO PHE TYR LYS PRO VAL ASP VAL GLU ALA LEU GLY SEQRES 4 B 110 LEU HIS ASP TYR CYS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 B 110 MET SER THR ILE LYS SER LYS LEU GLU ALA ARG GLU TYR SEQRES 6 B 110 ARG ASP ALA GLN GLU PHE GLY ALA ASP VAL ARG LEU MET SEQRES 7 B 110 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU SEQRES 8 B 110 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 B 110 MET ARG PHE ALA LYS MET SEQRES 1 C 110 GLY SER HIS MET GLU GLN LEU LYS CYS CYS SER GLY ILE SEQRES 2 C 110 LEU LYS GLU MET PHE ALA LYS LYS HIS ALA ALA TYR ALA SEQRES 3 C 110 TRP PRO PHE TYR LYS PRO VAL ASP VAL GLU ALA LEU GLY SEQRES 4 C 110 LEU HIS ASP TYR CYS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 C 110 MET SER THR ILE LYS SER LYS LEU GLU ALA ARG GLU TYR SEQRES 6 C 110 ARG ASP ALA GLN GLU PHE GLY ALA ASP VAL ARG LEU MET SEQRES 7 C 110 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU SEQRES 8 C 110 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 C 110 MET ARG PHE ALA LYS MET SEQRES 1 D 110 GLY SER HIS MET GLU GLN LEU LYS CYS CYS SER GLY ILE SEQRES 2 D 110 LEU LYS GLU MET PHE ALA LYS LYS HIS ALA ALA TYR ALA SEQRES 3 D 110 TRP PRO PHE TYR LYS PRO VAL ASP VAL GLU ALA LEU GLY SEQRES 4 D 110 LEU HIS ASP TYR CYS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 D 110 MET SER THR ILE LYS SER LYS LEU GLU ALA ARG GLU TYR SEQRES 6 D 110 ARG ASP ALA GLN GLU PHE GLY ALA ASP VAL ARG LEU MET SEQRES 7 D 110 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU SEQRES 8 D 110 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 D 110 MET ARG PHE ALA LYS MET HET QYV A 501 35 HET QYV B 501 35 HET QYV C 501 35 HET QYV D 501 35 HETNAM QYV 4-[2-(2,4-DIFLUOROPHENOXY)-5-(METHYLSULFONYL)PHENYL]-N- HETNAM 2 QYV ETHYL-6-METHYL-7-OXO-6,7-DIHYDRO-1H-PYRROLO[2,3- HETNAM 3 QYV C]PYRIDINE-2-CARBOXAMIDE FORMUL 5 QYV 4(C24 H21 F2 N3 O5 S) FORMUL 9 HOH *327(H2 O) HELIX 1 AA1 GLN A 353 PHE A 365 1 13 HELIX 2 AA2 ALA A 366 LYS A 368 5 3 HELIX 3 AA3 HIS A 369 TRP A 374 1 6 HELIX 4 AA4 PRO A 375 TYR A 377 5 3 HELIX 5 AA5 ASP A 381 GLY A 386 1 6 HELIX 6 AA6 ASP A 389 ILE A 394 1 6 HELIX 7 AA7 ASP A 399 ALA A 409 1 11 HELIX 8 AA8 ASP A 414 ASN A 433 1 20 HELIX 9 AA9 HIS A 437 LYS A 456 1 20 HELIX 10 AB1 MET B 351 ALA B 366 1 16 HELIX 11 AB2 HIS B 369 TRP B 374 1 6 HELIX 12 AB3 PRO B 375 TYR B 377 5 3 HELIX 13 AB4 ASP B 381 GLY B 386 1 6 HELIX 14 AB5 ASP B 389 ILE B 394 1 6 HELIX 15 AB6 ASP B 399 ALA B 409 1 11 HELIX 16 AB7 ASP B 414 ASN B 433 1 20 HELIX 17 AB8 HIS B 437 LYS B 456 1 20 HELIX 18 AB9 HIS C 350 PHE C 365 1 16 HELIX 19 AC1 ALA C 366 LYS C 368 5 3 HELIX 20 AC2 HIS C 369 TRP C 374 1 6 HELIX 21 AC3 PRO C 375 TYR C 377 5 3 HELIX 22 AC4 ASP C 381 GLY C 386 1 6 HELIX 23 AC5 ASP C 389 ILE C 394 1 6 HELIX 24 AC6 ASP C 399 ALA C 409 1 11 HELIX 25 AC7 ASP C 414 ASN C 433 1 20 HELIX 26 AC8 HIS C 437 ALA C 455 1 19 HELIX 27 AC9 MET D 351 PHE D 365 1 15 HELIX 28 AD1 ALA D 366 LYS D 368 5 3 HELIX 29 AD2 HIS D 369 TRP D 374 1 6 HELIX 30 AD3 PRO D 375 TYR D 377 5 3 HELIX 31 AD4 ASP D 381 GLY D 386 1 6 HELIX 32 AD5 ASP D 389 ILE D 394 1 6 HELIX 33 AD6 ASP D 399 ALA D 409 1 11 HELIX 34 AD7 ASP D 414 ASN D 433 1 20 HELIX 35 AD8 HIS D 437 ALA D 455 1 19 SITE 1 AC1 14 TRP A 374 PRO A 375 VAL A 380 ASP A 381 SITE 2 AC1 14 LEU A 385 ASN A 433 HIS A 437 GLU A 438 SITE 3 AC1 14 VAL A 439 MET A 442 HOH A 613 HOH A 623 SITE 4 AC1 14 ALA C 371 TRP C 374 SITE 1 AC2 16 TRP B 374 PRO B 375 PHE B 376 PRO B 379 SITE 2 AC2 16 VAL B 380 ASP B 381 LEU B 385 LEU B 387 SITE 3 AC2 16 ASN B 433 GLU B 438 VAL B 439 MET B 442 SITE 4 AC2 16 HOH B 613 HOH B 638 TRP D 374 QYV D 501 SITE 1 AC3 15 TRP A 374 TYR A 377 LYS A 378 TRP C 374 SITE 2 AC3 15 PRO C 375 PHE C 376 VAL C 380 ASP C 381 SITE 3 AC3 15 LEU C 385 LEU C 387 ASN C 433 GLU C 438 SITE 4 AC3 15 VAL C 439 HOH C 608 HOH C 635 SITE 1 AC4 17 TRP B 374 GLU B 438 QYV B 501 TRP D 374 SITE 2 AC4 17 PRO D 375 PHE D 376 VAL D 380 ASP D 381 SITE 3 AC4 17 LEU D 385 LEU D 387 ASN D 433 PRO D 434 SITE 4 AC4 17 VAL D 439 MET D 442 HOH D 605 HOH D 621 SITE 5 AC4 17 HOH D 630 CRYST1 162.420 40.710 86.300 90.00 106.05 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006157 0.000000 0.001771 0.00000 SCALE2 0.000000 0.024564 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012057 0.00000